Opportunities

Pricing

About Us

About Us

Kazakhstan License

Account Insurance

Contacts

Log in

Investlink: Trade & Invest

Investments, Trading US Stocks

Open

Opportunities
- Products
- Stocks
- Options
  New
- Deposit 2.0
- ETF
- Services
- Portfolio Investing
- Investment Consulting
- Signals
  New
- Tools
- Halal Compliance Check
- Premium Features
Pricing
About Us
- Company
- About Us
- Kazakhstan License
- Reliability & Protection
- Account Insurance
- Communication
- Contacts

ENG

RU

Log in

Главная
Теги

Zenas BioPharma

Bicara и Zenas собираются привлечь на IPO по $200 млн каждая

Так совпало, что обе биотех-компании располагаются в Бостоне: Bicara Therapeutics борется с плоскоклеточным раком головы...

09 сентября, 2024 | 3 минуты чтения

Request a consultation

Fill out the form to get a free professional investment consultation.

Close Submit

Download the Investlink App

Point your phone's camera at the QR code
to download the mobile app.

Close

User Agreement Privacy Policy

Products & Services Stocks ETF Options Deposit 2.0 Halal Compliance Check Pricing

Insurance Insurance

Company About Us Contacts

User Agreement Privacy Policy

General Investment Risks: Investing in financial instruments on the securities market involves risks. These risks include, but are not limited to, returns that may differ from expectations, partial or total loss of capital, and the possibility of incurring losses. Management Responsibility: Similar to the management of public companies, the management of Investlink does not bear personal responsibility to shareholders or investors regarding investment performance. Use of Historical Performance: The website provides information on historical performance, which is for reference only and does not guarantee similar results in the future. Investors should understand that past performance is not indicative of future results. Projected Returns: Statements regarding projected returns presented on the website are for illustrative purposes only and should not be considered as investment advice. Investors should be aware that actual results may differ significantly.